Patent wars: "The substance patent protecting CRESTOR (rosuvastatin) expires on 8 January 2016, and the pediatric exclusivity period expires 8 July 2016." This went to litigation. See: http://www.astrazeneca.com/Media/Press-releases/Article/20130325--astrazeneca-settles-litigation-over-crestor-patent
Answered 5/17/2015
2.8k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question